Deflazacort component is a corticosteroid used as an agent to treat Duchenne Muscular Dystrophy. The condition of DMS is an inherited disorder resulting from mutations of the dystrophin gene necessary for muscle function. It may cause serious muscle weakness, progressive breathing, cardiovascular disability, severely impacting people’s quality of life and survival. This medicine is available in oral tablet form.
Class of Drugs – Corticosteroids
Molecular Formula – C25H31NO6
Molecular Weight - 441.5 g/mol
Working: Given active component, Deflazacort belongs to a group of medications called corticosteroids. It acts by reducing inflammation and by changing the way the immune system works. The condition of DMS usually manifests by muscle weakness in early childhood followed by loss of the ability to walk. This active component delays the onset of muscle-related complications resulting from DMD. This drug may improve muscle strength and slow the progression of disability.
Uses: Corticosteroids medication Deflazacort is a steroid approved for the treatment of Duchenne muscular dystrophy in adults and children at least 2 years old. It does not cure muscular dystrophy, but it may improve muscle strength and slow the progression of disability.
Popular Brands and Dosages: This mentioned active ingredient can be used as the main active ingredient in medicines to treat muscle disorders. Following are popular brand medicines contains this ingredient:
- Emflaza: 6 mg
- Betnesol: 6 mg
- Kenacort: 6 mg
- Decadron: 6 mg
Stopping this medication abruptly may cause symptoms such as loss of appetite, an upset stomach, vomiting, drowsiness, confusion, headache, fever, joint and muscle pain, peeling skin, and weight loss. Do not consume alcoholic beverages or drugs like marijuana while consuming the above medicine.